Department of Molecular Oncology, Eastern Hepatobiliary Surgical Hospital & Institute, Second Military Medical University, Shanghai 200438, China.
Cancer Lett. 2013 Sep 1;337(2):226-36. doi: 10.1016/j.canlet.2013.05.007. Epub 2013 May 14.
MicroRNAs (miRNAs) have been believed to associate with malignant progression including cancer cell proliferation, apoptosis, differentiation, angiogenesis, invasion and metastasis. However, the functions of miRNAs are intricate, one miRNA can directly or indirectly target multiple genes and function as oncogene or tumor suppressor gene. In this study, we found that miR-21 inhibits PTEN and human sulfatase-1 (hSulf-1) expression in hepatocellular carcinoma (HCC) cells. The hSulf-1 is a heparin-degrading endosulfatase, which can inhibit the heparin binding growth factor-mediated signaling transduction into cells. Therefore, miR-21-mediated suppression of both hSulf-1 and PTEN led to activation of AKT/ERK pathways and epithelial-mesenchymal transition (EMT) in HCC cells, and finally enhance the activity of HCC cell proliferation and movement and promote HCC xenograft tumor growth in mouse models. These findings may provide candidate targets for prevention and treatment of HCC.
MicroRNAs (miRNAs) 被认为与恶性进展有关,包括癌细胞增殖、凋亡、分化、血管生成、侵袭和转移。然而,miRNAs 的功能错综复杂,一个 miRNA 可以直接或间接靶向多个基因,并作为癌基因或肿瘤抑制基因发挥作用。在本研究中,我们发现 miR-21 抑制肝癌 (HCC) 细胞中的 PTEN 和人硫酸酯酶-1 (hSulf-1) 的表达。hSulf-1 是一种肝素降解内硫酸酯酶,可抑制肝素结合生长因子介导的信号转导进入细胞。因此,miR-21 介导的 hSulf-1 和 PTEN 抑制导致 AKT/ERK 通路的激活和 HCC 细胞的上皮-间充质转化 (EMT),最终增强 HCC 细胞增殖和运动的活性,并促进 HCC 异种移植肿瘤在小鼠模型中的生长。这些发现可能为 HCC 的预防和治疗提供候选靶点。